The "Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.Report includes an overview of trial numbers and their average ...
Benzocaine gel: Over-the-counter gels or creams containing benzocaine, a topical anesthetic, can provide temporary relief by ...
Abdominal pain in your upper or lower pelvis where your bladder sits could have a non-infectious cause. Learn what causes ...
Head injuries may re-awaken dormant viruses in the brain, triggering the onset of conditions such as Alzheimer’s disease, an ...
British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the ...
Tufts and Oxford researchers found that head trauma reactivates HSV-1 in the brain, leading to neurodegeneration linked to ...
The study reveals a potential link between concussions and the activation of dormant viruses, which may lead to ...
Shingrix in 2017 received US FDA approval to prevent shingles in adults aged 50 and older. Since 2021, it has been approved for use in immunocompromised patients aged 18 and up. GSK estimates around ...
A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...
Researchers do not deny that infections like influenza, herpes and Hepatitis-C an lead to Parkinson's disease. However, more ...
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) fell 8.9% on Wednesday after UBS Group lowered their price target on the stock from $108.00 to $96.00. UBS Group currently has a buy rating on the stock.